IHEvsSLTYETF Comparison
iShares U.S. Pharmaceuticals ETF (IHE) belongs to the US Health Care segment. YieldMax Ultra Short Option Income Strategy ETF (SLTY) is part of the Alternatives segment. IHE's top 3 sector exposures are and Health Care. In contrast, SLTY's top sector exposures are and Consumer Discretionary.Industrials, Health Care, IHE is less expensive with a Total Expense Ratio (TER) of 0.38%, versus 1.24% for SLTY. IHE is up 12.18% year-to-date (YTD) with +$30M in YTD flows. SLTY performs worse with -7.55% YTD performance, and +$3M in YTD flows. Run a side-by-side ETF comparison of IHE and SLTY below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
IHE vs SLTY performance and flow charts
Performance
Cumulative Flows
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | IHE SLTY | +7.66%-2.40% | +9.75%-4.71% | +12.18%-7.55% | +42.29%n/a | +69.67%n/a | +64.77%n/a |
| Flows | IHE SLTY | +$38M+$607K | -$98M+$6M | +$30M+$3M | +$164M- | +$261M- | +$294M- |
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | IHE SLTY | +19.63%+13.85% | +17.30%n/a | +16.52%n/a | +16.23%n/a |
| Max drawdown | IHE SLTY | -4.47%-9.70% | -8.48%n/a | -16.04%n/a | -16.12%n/a |
| Max drawdown duration | IHE SLTY | 15d74d | 81dn/a | 210dn/a | 669dn/a |
IHE | SLTY | |
Last sale 6/12/2026 at 1:30 PM | $94.75 | $23.57 |
| Previous close 06/12/2026 | $95.07 | $23.56 |
| Consolidated volume 06/12/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Create an account to view replication metrics
IHE | SLTY | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
IHE | SLTY | |
|---|---|---|
| Last price | $94.75 | $23.57 |
| 1D performance | -0.34% | +0.04% |
| AuM | $981.06 M | $18.30 M |
| E/R | 0.38% | 1.24% |
IHE | SLTY | |
|---|---|---|
| Management strategy | Passive | Active |
| Provider | iShares | YieldMax ETFs |
| Benchmark | Dow Jones U.S. Select Pharmaceuticals Index | - |
| N° of holdings | 45 | 199 |
| Asset class | Equities | - |
| Trailing 12m distribution yield | Join | Join |
| Inception date | May 1, 2006 | August 21, 2025 |
| ESG | No | No |
Countries
Sectors
Diversification
Total weight of top 15 holdings out of 15
